Biogen, Sage Therapeutics Enter $1.5 Billion Deal To Develop, Sell Neurological Treatments Home > Business > Article
3 years ago By Naisinsh946 — Biogen Inc will take a $650 million stake in Sage Therapeutics and pay $875 million in upfront payment as they jointly develop and sell treatments for neur
#sage #therapeutics #enter #billion
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid Home > Health > Article
3 years ago By Tsuppana268 — /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company") announced today that the Toronto Stock Exchange (the "TS
#therapeutics #announces #approval #normal